Welcoming Dr. Jacob Larson to the Bibb Lab at the University of Arizona

We are excited to announce the latest addition to our team at the Bibb Lab in the Department of

Translational Neurosciences, College of Medicine-Phoenix, University of Arizona - Dr. Jacob

Larson, who is joining the team as a Research Scientist.

broken image


A Rich Academic Background

Dr. Larson brings a wealth of knowledge and expertise to our lab. With a Bachelor of Science in

Biochemistry from the University of New Mexico (UNM) and a Ph.D. in Pharmaceutical

Sciences, focusing on Chemical Biology from UNC Chapel Hill, his academic journey is nothing

short of impressive. His research during his Ph.D. honed his skills in biochemical High

Throughput Screening (HTS) assay development and biophysics, particularly in identifying and

characterizing novel ligands for various protein targets.


A Blend of Science and Strength

Outside the lab, Dr. Larson is just as dynamic. He is an avid powerlifting enthusiast, a testament

to his dedication and discipline - traits that he brings to his scientific work. In addition, his love

for hiking with his dogs and partner showcases his appreciation for nature and a well-rounded



Pioneering Research at Bibb Lab

In the Bibb Lab, Dr. Larson embarks on a crucial project focusing on CDK5, a protein kinase

with significant implications in the central nervous system (CNS) and oncology. Leveraging his

extensive experience in assay development, he aims to innovate new screening methods in

cellular and in vitro settings. His primary goal? To discover molecules capable of inhibiting

CDK5 activity and disrupting its interaction with its activators, P35 and P25.


A Bright Future Ahead

Dr. Larson's arrival marks a significant milestone for our lab. His unique blend of expertise in

pharmaceutical sciences and passion for exploring the unknown aligns perfectly with our

mission to advance the frontiers of translational neurosciences. We are thrilled to have him on

board and eagerly anticipate the contributions he will make to our ongoing research and the

broader scientific community. Welcome to the team, Dr. Larson!